Spectrophotometric Determination of Sodium Prodronate in Tablets for Osteoporosis Treatment.

Authors :: Bulyga, D. M.
Popova, O. P.
Rudakovskaya, E. B.
Kuvaeva, Z. I.
Lopatik, D. V.
Source :: Pharmaceutical Chemistry Journal. Dec2019, Vol. 53 Issue 9, p871-875. 5p.
Publication Year :: 2019
Abstract: A spectrophotometric method for determining sodium prodronate in tablets by measuring the absorption at 237 ± 2 nm of a Cu(II)—prodronate complex in acetate buffer was developed and validated. The method met applicable requirements of the SP RB for quantitative analysis methods for drugs and could be recommended for use by the State Drug Quality Control Inspection and technical control departments of chemical and pharmaceutical plants. [ABSTRACT FROM AUTHOR]

Subjects :: *SODIUM compounds
*CHEMICAL plants
*DRUG factories
*OSTEOPOROSIS
*DRUG analysis
*DRUG control
*QUALITY control

Full Text Access

Tools